| JXSB2101044 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-08-09 | | Medimmune LLC;Catalent Indiana LLC | | | view |
| JXSS2500037 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-03-28 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2300025 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2023-03-11 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSL2500017 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-01-24 | | Medimmune LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| JYSB2300139 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-08-17 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JXSS2500017 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-02-25 | | Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSB2200077 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-24 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JXSL2101125 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-11-05 | | Medimmune LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| JYSZ2400002 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | License Renew | 2024-01-03 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2300024 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2023-03-11 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSL2500018 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-01-24 | | Medimmune LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2101027 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-06-21 | | Medimmune LLC;Catalent Indiana LLC | | | view |
| JXSS2500014 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-02-21 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSB2200078 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-24 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JYSB2300121 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-07-14 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JXSS2500038 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-03-28 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSB2200123 | Durvalumab | durvalumab | Injection | Biological Products | Supplementary Application | 2022-09-27 | | Medimmune LLC;Catalent Indiana LLC | | | view |
| JYSZ2400001 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | License Renew | 2024-01-03 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSL2300031 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-02-02 | | Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2400096 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-10-18 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
